Bimi International Medical Inc (BIMI) - Net Assets
Based on the latest financial reports, Bimi International Medical Inc (BIMI) has net assets worth $10.14 Million USD as of September 2023. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($35.04 Million) and total liabilities ($24.90 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Bimi International Medical Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $10.14 Million |
| % of Total Assets | 28.94% |
| Annual Growth Rate | N/A |
| 5-Year Change | -47.75% |
| 10-Year Change | -83.63% |
| Growth Volatility | 42.82 |
Bimi International Medical Inc - Net Assets Trend (2002–2022)
This chart illustrates how Bimi International Medical Inc's net assets have evolved over time, based on quarterly financial data. See operational self-sufficiency of Bimi International Medical Inc to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Bimi International Medical Inc (2002–2022)
The table below shows the annual net assets of Bimi International Medical Inc from 2002 to 2022. For live valuation and market cap data, see market cap of Bimi International Medical Inc.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | $5.22 Million | -53.98% |
| 2021-12-31 | $11.34 Million | -32.89% |
| 2020-12-31 | $16.89 Million | +98.45% |
| 2019-12-31 | $8.51 Million | -14.75% |
| 2018-12-31 | $9.99 Million | -63.42% |
| 2017-12-31 | $27.30 Million | +2.21% |
| 2016-12-31 | $26.71 Million | -12.08% |
| 2015-12-31 | $30.38 Million | -3.05% |
| 2014-12-31 | $31.33 Million | -1.67% |
| 2013-12-31 | $31.86 Million | +6.88% |
| 2012-12-31 | $29.81 Million | +1.00% |
| 2011-12-31 | $29.52 Million | +12.42% |
| 2010-12-31 | $26.26 Million | +27.34% |
| 2009-12-31 | $20.62 Million | +32.62% |
| 2008-12-31 | $15.55 Million | +69.67% |
| 2007-12-31 | $9.16 Million | +75.29% |
| 2006-12-31 | $5.23 Million | +919.93% |
| 2005-12-31 | $-637.59K | -55.64% |
| 2004-12-31 | $-409.66K | -60.50% |
| 2003-12-31 | $-255.23K | -43.06% |
| 2002-12-31 | $-178.41K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Bimi International Medical Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 6951569700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $3.77K | 0.09% |
| Other Comprehensive Income | $24.58K | 0.61% |
| Other Components | $74.16 Million | 1832.23% |
| Total Equity | $4.05 Million | 100.00% |
Bimi International Medical Inc Competitors by Market Cap
The table below lists competitors of Bimi International Medical Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bangkok Expressway and Metro PCL F
F:B4X
|
$1.49K |
|
Fox Marble Holdings PLC
LSE:FOX
|
$1.52K |
|
Ordinary Fully Paid Deferred Settlement
AU:EPXDA
|
$1.53K |
|
Cuu Long Petro Urban Development and Investment Corp
VN:CCL
|
$1.53K |
|
BANPU PCL -FGN- BA 1
F:BPFG
|
$1.39K |
|
Ordinary Fully Paid Deferred Settlement
AU:VMLDB
|
$1.36K |
|
Sonder Holdings Inc. Class A
NASDAQ:SONDQ
|
$1.33K |
|
Mazhar Zorlu Holding AS
IS:MZHLD
|
$1.32K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bimi International Medical Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from 11,193,430 to 4,047,691, a change of -7,145,739 (-63.8%).
- Net loss of 22,393,000 reduced equity.
- New share issuances of 5,000,000 increased equity.
- Other comprehensive income decreased equity by 3,841,144.
- Other factors increased equity by 14,088,405.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-22.39 Million | -553.23% |
| Share Issuances | $5.00 Million | +123.53% |
| Other Comprehensive Income | $-3.84 Million | -94.9% |
| Other Changes | $14.09 Million | +348.06% |
| Total Change | $- | -63.84% |
Book Value vs Market Value Analysis
This analysis compares Bimi International Medical Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | $-163.38 | $0.00 | x |
| 2003-12-31 | $-263.13 | $0.00 | x |
| 2004-12-31 | $-422.33 | $0.00 | x |
| 2005-12-31 | $-570.80 | $0.00 | x |
| 2006-12-31 | $505.64 | $0.00 | x |
| 2007-12-31 | $107.12 | $0.00 | x |
| 2008-12-31 | $146.22 | $0.00 | x |
| 2009-12-31 | $193.55 | $0.00 | x |
| 2010-12-31 | $240.52 | $0.00 | x |
| 2011-12-31 | $270.58 | $0.00 | x |
| 2012-12-31 | $273.29 | $0.00 | x |
| 2013-12-31 | $290.84 | $0.00 | x |
| 2014-12-31 | $276.20 | $0.00 | x |
| 2015-12-31 | $242.43 | $0.00 | x |
| 2016-12-31 | $203.07 | $0.00 | x |
| 2017-12-31 | $192.61 | $0.00 | x |
| 2018-12-31 | $1.34 | $0.00 | x |
| 2019-12-31 | $53.14 | $0.00 | x |
| 2020-12-31 | $78.29 | $0.00 | x |
| 2021-12-31 | $20.87 | $0.00 | x |
| 2022-12-31 | $1.52 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bimi International Medical Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -553.23%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -189.29%
- • Asset Turnover: 0.33x
- • Equity Multiplier: 8.82x
- Recent ROE (-553.23%) is below the historical average (-48.79%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 0.00% | -66194.40% | 0.19x | 0.00x | $-313.13K |
| 2003 | 0.00% | 0.00% | 0.00x | 0.00x | $-266.55K |
| 2004 | 0.00% | 0.00% | 0.00x | 0.00x | $-303.39K |
| 2005 | 0.00% | 0.00% | 0.00x | 0.00x | $-335.50K |
| 2006 | 15.13% | 15.01% | 0.81x | 1.24x | $268.18K |
| 2007 | 22.58% | 20.02% | 0.95x | 1.19x | $1.15 Million |
| 2008 | 23.50% | 23.07% | 0.88x | 1.16x | $2.10 Million |
| 2009 | 23.16% | 23.50% | 0.78x | 1.26x | $2.71 Million |
| 2010 | 16.39% | 16.96% | 0.75x | 1.30x | $1.68 Million |
| 2011 | 6.93% | 13.70% | 0.34x | 1.48x | $-905.78K |
| 2012 | 0.30% | 0.95% | 0.22x | 1.44x | $-2.89 Million |
| 2013 | -0.56% | -3.17% | 0.13x | 1.34x | $-3.37 Million |
| 2014 | -1.97% | -6.18% | 0.21x | 1.54x | $-3.75 Million |
| 2015 | -3.19% | -14.43% | 0.15x | 1.46x | $-4.01 Million |
| 2016 | -6.81% | -30.09% | 0.16x | 1.40x | $-4.49 Million |
| 2017 | -5.76% | -18.45% | 0.21x | 1.52x | $-4.29 Million |
| 2018 | -165.62% | -256.59% | 0.28x | 2.27x | $-17.80 Million |
| 2019 | -51.13% | -2809.88% | 0.01x | 3.46x | $-5.31 Million |
| 2020 | -31.68% | -41.21% | 0.39x | 1.99x | $-6.96 Million |
| 2021 | -312.56% | -164.10% | 0.56x | 3.41x | $-36.11 Million |
| 2022 | -553.23% | -189.29% | 0.33x | 8.82x | $-22.80 Million |
Industry Comparison
This section compares Bimi International Medical Inc's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $3,379,419,546
- Average return on equity (ROE) among peers: -24.07%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bimi International Medical Inc (BIMI) | $10.14 Million | 0.00% | 2.46x | $1.40K |
| High Tide Inc (HITI) | $152.00 Million | -22.60% | 0.62x | $204.80 Million |
| Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) | $4.99 Million | -0.54% | 0.89x | $5.10 Million |
| PetMed Express Inc (PETS) | $97.00 Million | 21.52% | 0.10x | $38.52 Million |
| POMDOCTOR LIMITED American Depositary Shares (POM) | $-309.35 Million | 0.00% | 0.00x | $9.70 Million |
| Ridgetech, Inc. (RDGT) | $18.86 Million | -90.44% | 2.91x | $1.34 Million |
| Scienture Holdings, Inc. (SCNX) | $3.77 Million | -141.00% | 0.53x | $14.87 Million |
| SunLink Health Systems Inc (SSY) | $42.39 Million | 2.15% | 1.53x | $7.85 Million |
| Walgreens Boots Alliance Inc (WBA) | $30.41 Billion | 14.26% | 1.96x | $10.37 Billion |
| Wellgistics Health, Inc. Common Stock (WGRX) | $-2.90 Million | 0.00% | 0.00x | $9.27 Million |
About Bimi International Medical Inc
BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical solution, and pharmaceutical and other healthcare products in the People's Republic of China and the United States. The company operates through four segments: Medical Devices; Healthcare Products; Wholesale Pharmaceuticals; and Pharmacy Retail. The Pharmacy Retail segment offers prescr… Read more